Alert: Today's new buy alert is SMPP SMPP has experienced a remarkable 2019 thus far, and could be positioned for another breakout higher. It is difficult to have the advantage in an industry where sales are predicted to be over $20 Billion in just a few years time, but one such cannabis company is likely to have a very promising future. SMPP is a "vertically integrated CBD company" with "one of the widest selections of efficacious full spectrum CBD products for various end users in the US." Unlike most companies that are focusing solely on direct to consumer, SMPP's "mission" is to be in "control" of "all facets of the supply chain." This could be a potentially massive competitive advantage over other companies in the sector as it could give SMPP the ability to "best maximize profits, control quality and manage...growth without needing or relying upon outside factors." Growth of "consumer spending on legal cannabis" is expected to "accelerate in 2019, jumping 38% to $16.9 billion" and this number is expected "to reach $31.3 billion in 2022." Most recently, "Illinois became the first state to pass a bill legalizing marijuana sales through the legislature." Last week, it was reported that "Top Congressional Republican Notes 'A Lot Of Bipartisanship' On Marijuana Banking Bill" and "Senate Hearing On Marijuana Banking Bill Could Happen This Month." A Senate hearing on cannabis business banking access would represent another significant victory for the cannabis reform movement that could further accelerate growth. Not only that, but "CBD for medical use is legal in 46 states" and "CBD derived from hemp rather than marijuana is legal in all states" according to Fortune Magazine. As reported by Fortune, a study found that "CBD Market Could Reach $16 Billion by 2025" and another study estimates that "hemp-CBD market alone could hit $22 billion by 2022." Furthermore, SMPP's "mission is to deliver clinically studied full spectrum CBD in a variety of delivery systems to an emerging market of consumers in pain conditions ranging from joint and arthritis to more acute pains stemming from all kinds of diseases and surgeries," presenting it with a potentially large market opportunity. In addition, most recently the company announced: - "Strategic Management Opportunity Corporation Finalizes Acquisition of US Canniceuticals, LLC
- "Strategic Management Opportunity Corporation CBD Inventory Procurement"
SMPP could be one of the most overlooked opportunities in this sector and could be positioned for a breakout higher. With their explosive sales campaign, their initial harvest combined with current inventory could yield $2.4 million in CBD sales from one single field this season. Get the FULL DETAILS HERE! You can do your own research and add SMPP to your trading screen today! We make no promises, but this could be the next big 100%+ you're looking for. Happy Trading! Inside Wall Street |
No comments:
Post a Comment